| Financial Year |
March 31 2023 |
| Monetary Funds |
444,541,552.53 |
| Held-for-trading Financial Assets |
357,369,385.91 |
| Notes Receivable |
-- |
| Accounts Receivable |
378,635,166.41 |
| Advances to Suppliers |
55,632,314.49 |
| Other Receivables |
18,118,836.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
143,274,540.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,863,467.43 |
| Total Current Assets |
1,419,435,263.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,722,654.02 |
| Fixed Assetes |
115,634,453.51 |
| Under-construction Projects |
50,975,452.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,382,930.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
828,962.82 |
| Deferred Income Tax Assets |
6,041,867.08 |
| Other Non-Current Assets |
4,151,592.14 |
| Sub-Total of Non-Current Assets |
234,437,202.82 |
| Total Assets |
1,653,872,466.79 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
161,409,863.51 |
| Accounts Payable |
174,169,983.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,521,069.28 |
| Taxes Payable |
9,480,225.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,320,721.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
330,337.62 |
| Other Current Liabilities |
224,084.92 |
| Sub-Total of Current Liabilities |
460,047,789.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,142,518.13 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,508,576.45 |
| Total Liabilities |
463,556,366.40 |
| Paid-In Capital(Or Share Stock) |
194,240,000.00 |
| Capital Surplus |
583,706,734.35 |
| Surplus Reserve |
52,112,302.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
305,390,213.42 |
| Minority Stockholder's Interest |
51,441,275.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,138,874,824.89 |
| Owner's Equity（Stockholder's Equity） |
1,190,316,100.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,653,872,466.79 |
